Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 May;241(1):228-40.
doi: 10.1111/j.1600-065X.2011.01016.x.

Immune tolerance in multiple sclerosis

Affiliations
Review

Immune tolerance in multiple sclerosis

Joan M Goverman. Immunol Rev. 2011 May.

Abstract

Multiple sclerosis is believed to be mediated by T cells specific for myelin antigens that circulate harmlessly in the periphery of healthy individuals until they are erroneously activated by an environmental stimulus. Upon activation, the T cells enter the central nervous system and orchestrate an immune response against myelin. To understand the initial steps in the pathogenesis of multiple sclerosis, it is important to identify the mechanisms that maintain T-cell tolerance to myelin antigens and to understand how some myelin-specific T cells escape tolerance and what conditions lead to their activation. Central tolerance strongly shapes the peripheral repertoire of myelin-specific T cells, as most myelin-specific T cells are eliminated by clonal deletion in the thymus. Self-reactive T cells that escape central tolerance are generally capable only of low-avidity interactions with antigen-presenting cells. Despite the low avidity of these interactions, peripheral tolerance mechanisms are required to prevent spontaneous autoimmunity. Multiple peripheral tolerance mechanisms for myelin-specific T cells have been identified, the most important of which appears to be regulatory T cells. While most studies have focused on CD4(+) myelin-specific T cells, interesting differences in tolerance mechanisms and the conditions that abrogate these mechanisms have recently been described for CD8(+) myelin-specific T cells.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflicts of interest.

Similar articles

Cited by

References

    1. Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol. 2009;9:393–407. - PMC - PubMed
    1. Stromnes IM, Goverman JM. Active induction of experimental allergic encephalomyelitis. Nat Protocols. 2006;1:1810–9. - PubMed
    1. Raine C. The Lesion in Multiple Sclerosis and Chronic Relapsing Experimental Allergic Encephalomyelitis: A Structural Comparison. In: Raine CS, McFarland HF, Tourtellotte WW, editors. Multiple Sclerosis: Clinical and Pathogenetic Basis. London: Chapman and Hall; 1997. pp. 243–86.
    1. Goverman J, Perchellet A, Huseby ES. The role of CD8(+) T cells in multiple sclerosis and its animal models. Curr Drug Targets Inflamm Allergy. 2005;4:239–45. - PubMed
    1. Friese MA, Fugger L. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain. 2005;128:1747–63. - PubMed

Publication types

MeSH terms